Bumper Offer - Urjas oil Just @ Rs. 1
StayHappi Alfuzosin Prolonged Release Tablet is an allopathic medicine The correct dosage of StayHappi Alfuzosin Prolonged Release Tablet depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
StayHappi Alfuzosin Prolonged Release Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Based on research, the following side effects have been observed when StayHappi Alfuzosin Prolonged Release Tablet is used -
Moderate
Mild
Is the use of StayHappi Alfuzosin Prolonged Release Tablet safe for pregnant women?
Pregnant women can take StayHappi Alfuzosin Prolonged Release Tablet without worrying about any side effects.
Is the use of StayHappi Alfuzosin Prolonged Release Tablet safe during breastfeeding?
There is no research available on the side effects of StayHappi Alfuzosin Prolonged Release Tablet in breastfeeding women. Therefore, its impact is unknown.
What is the effect of StayHappi Alfuzosin Prolonged Release Tablet on the Kidneys?
StayHappi Alfuzosin Prolonged Release Tablet may have mild side effects on the kidneys.
What is the effect of StayHappi Alfuzosin Prolonged Release Tablet on the Liver?
Use of StayHappi Alfuzosin Prolonged Release Tablet may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of StayHappi Alfuzosin Prolonged Release Tablet on the Heart?
Very few cases of side effects of StayHappi Alfuzosin Prolonged Release Tablet on the heart have been reported.
StayHappi Alfuzosin Prolonged Release Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
If you are suffering from any of the following diseases, you should not take StayHappi Alfuzosin Prolonged Release Tablet unless your doctor advises you to do so -
Is this StayHappi Alfuzosin Prolonged Release Tablet habit forming or addictive?
No, there is no any evidence that StayHappi Alfuzosin Prolonged Release Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
StayHappi Alfuzosin Prolonged Release Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
StayHappi Alfuzosin Prolonged Release Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, StayHappi Alfuzosin Prolonged Release Tablet is not used to treat mental disorders.
Interaction between Food and StayHappi Alfuzosin Prolonged Release Tablet
StayHappi Alfuzosin Prolonged Release Tablet may take longer to act if you eat some foods while taking it. Follow your doctor's advice on this.
Interaction between Alcohol and StayHappi Alfuzosin Prolonged Release Tablet
Drinking alcohol while taking StayHappi Alfuzosin Prolonged Release Tablet may lead to slight side effects. If you experience any side effects, contact your doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Uroxatral® (alfuzosin HCL)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 123-124
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Uroxatral® (alfuzosin HCL)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 142
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 123-124
